These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 38992688)
1. Targeting CSF1R in myeloid-derived suppressor cells: insights into its immunomodulatory functions in colorectal cancer and therapeutic implications. Tong X; Qiao S; Dong Z; Zhao X; Du X; Niu W J Nanobiotechnology; 2024 Jul; 22(1):409. PubMed ID: 38992688 [TBL] [Abstract][Full Text] [Related]
2. Plasmodium yoelii Infection Enhances the Expansion of Myeloid-Derived Suppressor Cells via JAK/STAT3 Pathway. Zhu Y; Zhou L; Mo L; Hong C; Pan L; Lin J; Qi Y; Tan S; Qian M; Hu T; Zhao Y; Qiu H; Lin P; Ma X; Yang Q J Immunol; 2024 Jul; 213(2):170-186. PubMed ID: 38819229 [TBL] [Abstract][Full Text] [Related]
3. Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy. Adeshakin AO; Liu W; Adeshakin FO; Afolabi LO; Zhang M; Zhang G; Wang L; Li Z; Lin L; Cao Q; Yan D; Wan X Cell Immunol; 2021 Apr; 362():104286. PubMed ID: 33524739 [TBL] [Abstract][Full Text] [Related]
4. Autocrine IL6-Mediated Activation of the STAT3-DNMT Axis Silences the TNFα-RIP1 Necroptosis Pathway to Sustain Survival and Accumulation of Myeloid-Derived Suppressor Cells. Smith AD; Lu C; Payne D; Paschall AV; Klement JD; Redd PS; Ibrahim ML; Yang D; Han Q; Liu Z; Shi H; Hartney TJ; Nayak-Kapoor A; Liu K Cancer Res; 2020 Aug; 80(15):3145-3156. PubMed ID: 32554751 [TBL] [Abstract][Full Text] [Related]
5. Decidua-derived granulocyte macrophage colony-stimulating factor induces polymorphonuclear myeloid-derived suppressor cells from circulating CD15+ neutrophils. Li C; Chen C; Kang X; Zhang X; Sun S; Guo F; Wang Q; Kou X; Bai W; Zhao A Hum Reprod; 2020 Dec; 35(12):2677-2691. PubMed ID: 33067638 [TBL] [Abstract][Full Text] [Related]
6. The mechanism of the premetastatic niche facilitating colorectal cancer liver metastasis generated from myeloid-derived suppressor cells induced by the S1PR1-STAT3 signaling pathway. Lin Q; Ren L; Jian M; Xu P; Li J; Zheng P; Feng Q; Yang L; Ji M; Wei Y; Xu J Cell Death Dis; 2019 Sep; 10(10):693. PubMed ID: 31534132 [TBL] [Abstract][Full Text] [Related]
7. Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade. Grauers Wiktorin H; Nilsson MS; Kiffin R; Sander FE; Lenox B; Rydström A; Hellstrand K; Martner A Cancer Immunol Immunother; 2019 Feb; 68(2):163-174. PubMed ID: 30315349 [TBL] [Abstract][Full Text] [Related]
8. Tumor-associated GM-CSF overexpression induces immunoinhibitory molecules via STAT3 in myeloid-suppressor cells infiltrating liver metastases. Thorn M; Guha P; Cunetta M; Espat NJ; Miller G; Junghans RP; Katz SC Cancer Gene Ther; 2016 Jun; 23(6):188-98. PubMed ID: 27199222 [TBL] [Abstract][Full Text] [Related]
9. Characterization of a p53/miR-34a/CSF1R/STAT3 Feedback Loop in Colorectal Cancer. Shi X; Kaller M; Rokavec M; Kirchner T; Horst D; Hermeking H Cell Mol Gastroenterol Hepatol; 2020; 10(2):391-418. PubMed ID: 32304779 [TBL] [Abstract][Full Text] [Related]
10. Suppression of Mll1-Complex by Stat3/Cebpβ-Induced miR-21a/21b/181b Maintains the Accumulation, Homeostasis, and Immunosuppressive Function of Polymorphonuclear Myeloid-Derived Suppressor Cells. Zhang Z; Huang X; Wang E; Huang Y; Yang R J Immunol; 2020 Jun; 204(12):3400-3415. PubMed ID: 32358019 [TBL] [Abstract][Full Text] [Related]
11. IL-1β-Induced Elevation of Solute Carrier Family 7 Member 11 Promotes Hepatocellular Carcinoma Metastasis Through Up-regulating Programmed Death Ligand 1 and Colony-Stimulating Factor 1. He Q; Liu M; Huang W; Chen X; Zhang B; Zhang T; Wang Y; Liu D; Xie M; Ji X; Sun M; Tian D; Xia L Hepatology; 2021 Dec; 74(6):3174-3193. PubMed ID: 34288020 [TBL] [Abstract][Full Text] [Related]
12. TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti-PD-1 Therapy in Melanoma. Holtzhausen A; Harris W; Ubil E; Hunter DM; Zhao J; Zhang Y; Zhang D; Liu Q; Wang X; Graham DK; Frye SV; Earp HS Cancer Immunol Res; 2019 Oct; 7(10):1672-1686. PubMed ID: 31451482 [TBL] [Abstract][Full Text] [Related]
13. STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells. Guha P; Gardell J; Darpolor J; Cunetta M; Lima M; Miller G; Espat NJ; Junghans RP; Katz SC Oncogene; 2019 Jan; 38(4):533-548. PubMed ID: 30158673 [TBL] [Abstract][Full Text] [Related]
14. Polyunsaturated fatty acids promote the expansion of myeloid-derived suppressor cells by activating the JAK/STAT3 pathway. Yan D; Yang Q; Shi M; Zhong L; Wu C; Meng T; Yin H; Zhou J Eur J Immunol; 2013 Nov; 43(11):2943-55. PubMed ID: 23897117 [TBL] [Abstract][Full Text] [Related]
15. IL-17 inhibits the accumulation of myeloid-derived suppressor cells in breast cancer via activating STAT3. Ma M; Huang W; Kong D Int Immunopharmacol; 2018 Jun; 59():148-156. PubMed ID: 29655056 [TBL] [Abstract][Full Text] [Related]
16. Expansion and activation of monocytic-myeloid-derived suppressor cell via STAT3/arginase-I signaling in patients with ankylosing spondylitis. Liu YF; Zhuang KH; Chen B; Li PW; Zhou X; Jiang H; Zhong LM; Liu FB Arthritis Res Ther; 2018 Aug; 20(1):168. PubMed ID: 30075733 [TBL] [Abstract][Full Text] [Related]
17. Lysosomal acid lipase, CSF1R, and PD-L1 determine functions of CD11c+ myeloid-derived suppressor cells. Zhao T; Liu S; Ding X; Johnson EM; Hanna NH; Singh K; Sen CK; Wan J; Du H; Yan C JCI Insight; 2022 Sep; 7(17):. PubMed ID: 35917184 [TBL] [Abstract][Full Text] [Related]
18. Early Activation of Myeloid-Derived Suppressor Cells Participate in Sepsis-Induced Immune Suppression via PD-L1/PD-1 Axis. Ruan WS; Feng MX; Xu J; Xu YG; Song CY; Lin LY; Li L; Lu YQ Front Immunol; 2020; 11():1299. PubMed ID: 32719675 [No Abstract] [Full Text] [Related]
19. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells. Deng Y; Cheng J; Fu B; Liu W; Chen G; Zhang Q; Yang Y Oncogene; 2017 Feb; 36(8):1090-1101. PubMed ID: 27593937 [TBL] [Abstract][Full Text] [Related]
20. JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors. Pennel KAF; Hatthakarnkul P; Wood CS; Lian GY; Al-Badran SSF; Quinn JA; Legrini A; Inthagard J; Alexander PG; van Wyk H; Kurniawan A; Hashmi U; Gillespie MA; Mills M; Ammar A; Hay J; Andersen D; Nixon C; Rebus S; Chang DK; Kelly C; Harkin A; Graham J; Church D; Tomlinson I; Saunders M; Iveson T; Lannagan TRM; Jackstadt R; Maka N; Horgan PG; Roxburgh CSD; Sansom OJ; McMillan DC; Steele CW; Jamieson NB; Park JH; Roseweir AK; Edwards J J Exp Clin Cancer Res; 2024 Mar; 43(1):64. PubMed ID: 38424636 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]